COST ACTION CA15135 MuTaLig & Companies: the multi-targeting drug discovery with implications at industrial level, 3rd Annual Meeting
Congress and symposium participations > Congress · 2018
Authors: Gülşah BAYRAKTAR
2018-2018, COST ACTION CA15135 MuTaLig & Companies: the multi-targeting drug discovery with implications at industrial level, 3rd Annual Meeting, Congress, Attendee, Malta, Valletta